A Longitudinal Investigation of Psychotropic and Non-Psychotropic Medication Use Among Adolescents and Adults with Autism Spectrum Disorders

被引：135

作者：

Esbensen, Anna J. ^{[1
]}

Greenberg, Jan S. ^{[1
]}

Seltzer, Marsha Mailick ^{[1
]}

Aman, Michael G. ^{[2
]}

机构：

[1] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA

[2] Ohio State Univ, Nisonger Ctr, Columbus, OH 43210 USA

来源：

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS | 2009年 / 39卷 / 09期

关键词：

ASD; Medication; Psychotropic medication; Non-psychotropic medication; PERVASIVE DEVELOPMENTAL DISORDERS; ATYPICAL ANTIPSYCHOTICS; PSYCHOACTIVE MEDICINES; PATTERNS; CHILDREN; PREVALENCE; SYMPTOMS; PHARMACOTHERAPY; DISABILITIES; RISPERIDONE;

D O I：

10.1007/s10803-009-0750-3

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

Medication use was examined in 286 adolescents and adults with ASD over a 4.5 year period. A total of 70% were taking a psychotropic or non-psychotropic medication at the beginning of the study. Both the number of psychotropic and non-psychotropic medications taken, and the proportion of individuals taking these medications, increased significantly over the study period, with 81% taking at least one medication 4.5 years later. Our findings suggested a high likelihood of staying medicated over time. Thus, adolescents and adults with ASD are a highly and increasingly medicated population.

引用

页码：1339 / 1349

页数：11

共 42 条

[1] Medication patterns in patients with autism: Temporal, regional, and demographic influences [J].

Aman, MG ;

Lam, KSL ;

Van Bourgondien, ME .

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (01) :116-126

[2]

Aman MG, 1999, MENT RETARD DEV D R, V5, P279, DOI 10.1002/(SICI)1098-2779(1999)5:4<279::AID-MRDD5>3.0.CO

[3]

2-6

[4] PSYCHOTROPIC AND ANTICONVULSANT DRUGS IN SUBJECTS WITH AUTISM - PREVALENCE AND PATTERNS OF USE [J].

AMAN, MG ;

VANBOURGONDIEN, ME ;

WOLFORD, PL ;

SARPHARE, G .

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1995, 34 (12) :1672-1681

[5] Stimulant drugs in the developmental disabilities revisited [J].

Aman, MG .

JOURNAL OF DEVELOPMENTAL AND PHYSICAL DISABILITIES, 1996, 8 (04) :347-365

[6]

Aman MG, 1999, MENT RETARD DEV D R, V5, P253, DOI 10.1002/(SICI)1098-2779(1999)5:4<253::AID-MRDD2>3.0.CO

[7]

2-R

[8] Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders [J].

Aman, MG ;

Langworthy, KS .

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2000, 30 (05) :451-459

[9] Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio [J].

Aman, MG ;

Lam, KSL ;

Collier-Crespin, A .

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2003, 33 (05) :527-534

[10] Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders [J].

Aman, Michael G. ;

Farmer, Cristan A. ;

Hollway, Jill ;

Arnold, L. Eugene .

CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2008, 17 (04) :713-+

← 1 2 3 4 5 →